Strategies for suppressing the function of oncogenic Ras protein in tumors

R-Ras contributes to LTP and contextual discrimination.

Neuroscience·2014

RalA suppresses early stages of Ras-induced squamous cell carcinoma progression.

Oncogene·2009

Hippocampus-dependent learning and memory is impaired in mice lacking the Ras-guanine-nucleotide releasing factor 1 (Ras-GRF1).

Neuropharmacology·2001

Basis for signaling specificity difference between Sos and Ras-GRF guanine nucleotide exchange factors.

The Journal of biological chemistry·2001

Prenylation of target GTPases contributes to signaling specificity of Ras-guanine nucleotide exchange factors.

The Journal of biological chemistry·2001

Solution structure of the Reps1 EH domain and characterization of its binding to NPF target sequences.

Biochemistry·2001

Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention.

Journal of the National Cancer Institute·2026

Treatment Effect Discrepancy Between PFS and OS in Antibody-Drug Conjugate Trials for Metastatic Breast Cancer: A Meta-Epidemiologic Analysis.

Journal of the National Cancer Institute·2026

Integrating genetic predictors into subsequent breast cancer risk prediction in survivors of childhood cancer.

Journal of the National Cancer Institute·2026

(Neo)adjuvant approvals for solid tumors by the US Food and Drug Administration 2010-2023.

Journal of the National Cancer Institute·2026

The floor, not the ceiling: industry ties across the cancer ecosystem.

Journal of the National Cancer Institute·2026

Cancer incidence trends among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 2000-2022.

Journal of the National Cancer Institute·2026

A single-center retrospective study evaluating the efficacy of anlotinib plus temozolomide for recurrent glioma based on real-world data.

Translational cancer research·2026

Mechanism of miR-188-5p enhancing radioresistance in nasopharyngeal carcinoma by targeting PTEN to activate the PI3K/Akt signaling pathway.

Translational cancer research·2026

A real-world feasibility and safety study of anlotinib monotherapy in heavily pretreated or temozolomide-ineligible recurrent malignant glioma.

Translational cancer research·2026

Remodeling the tumor immune microenvironment: mechanisms of crosstalk between regulated cell death macrophages.

Frontiers in immunology·2026

Stem cell-derived exosomes preserve diabetic islet function: a systematic review and meta-analysis of preclinical studies.

Biophysics reports·2026

Pathological role of deubiquitinating enzymes in lung cancer: recent insights and advances.

American journal of cancer research·2026

Related Experiment Videos

Strategies for suppressing the function of oncogenic Ras protein in tumors

Related Concept Videos

R-Ras contributes to LTP and contextual discrimination.

RalA suppresses early stages of Ras-induced squamous cell carcinoma progression.

Hippocampus-dependent learning and memory is impaired in mice lacking the Ras-guanine-nucleotide releasing factor 1 (Ras-GRF1).

Basis for signaling specificity difference between Sos and Ras-GRF guanine nucleotide exchange factors.

Prenylation of target GTPases contributes to signaling specificity of Ras-guanine nucleotide exchange factors.

Solution structure of the Reps1 EH domain and characterization of its binding to NPF target sequences.

Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention.

Treatment Effect Discrepancy Between PFS and OS in Antibody-Drug Conjugate Trials for Metastatic Breast Cancer: A Meta-Epidemiologic Analysis.

Integrating genetic predictors into subsequent breast cancer risk prediction in survivors of childhood cancer.

(Neo)adjuvant approvals for solid tumors by the US Food and Drug Administration 2010-2023.

The floor, not the ceiling: industry ties across the cancer ecosystem.

Cancer incidence trends among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 2000-2022.

A single-center retrospective study evaluating the efficacy of anlotinib plus temozolomide for recurrent glioma based on real-world data.

Mechanism of miR-188-5p enhancing radioresistance in nasopharyngeal carcinoma by targeting PTEN to activate the PI3K/Akt signaling pathway.

A real-world feasibility and safety study of anlotinib monotherapy in heavily pretreated or temozolomide-ineligible recurrent malignant glioma.

Remodeling the tumor immune microenvironment: mechanisms of crosstalk between regulated cell death macrophages.

Stem cell-derived exosomes preserve diabetic islet function: a systematic review and meta-analysis of preclinical studies.

Pathological role of deubiquitinating enzymes in lung cancer: recent insights and advances.

Related Experiment Videos

Strategies for suppressing the function of oncogenic Ras protein in tumors

Related Concept Videos

Related Articles